Quick Answer
Lakefront Biotherapeutics NV reported Total Assets of $3.41 billion for fiscal year 2025.
Lakefront Biotherapeutics NV Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $3.41B | -17.6% |
| 2024 | $4.14B | -5.1% |
| 2023 | $4.36B | -8.0% |
| 2022 | $4.73B | -8.8% |
| 2021 | $5.19B | -9.2% |
| 2020 | $5.72B | -5.8% |
| 2019 | $6.07B | +321.6% |
| 2018 | $1.44B | +11.9% |
| 2017 | $1.29B | +18.7% |
| 2016 | $1.08B | +144.8% |
| 2015 | $442.51M | — |
- Lakefront Biotherapeutics NV showed a decrease of -17.6% in Total Assets compared to the prior fiscal year.
- Over the 2015–2025 period, Lakefront Biotherapeutics NV’s total assets has grown by 669.8% (from $442.51 million to $3.41 billion).
- The most recent figure is from Lakefront Biotherapeutics NV’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: